Attenzione! I contenuti di questa pagina sono disponibili solo nelle seguenti lingue: Inglese
Comecer will be present at A3P Barrier Technology at Beaumont Palace, Pau, France.
We will be showing the latest developments in barrier technology for Pharma and ATMP.
You will have the possibility to meet at Tabletop #7 our Area Sales Manager, Mirko Tassinari and our Regenerative Medicine Specialist, Marco Fadda and get all the details on how Comecer capabilities in customized aseptic automation integrated within isolator technology can catch the specific requirements of your filling and assembly line.
Come and talk to our experts regarding the Comecer products that interest you the most, in particular FlexyCultTM and MCCI.
This is a good opportunity to understand exactly how these two interact.
|FlexyCultTM is a multiple single-batch incubation system connected to a shared utilities docking station that can help scale up your cell culturing procedures.|
|MCCI (Modular Cell Culture Isolator) is a new generation of isolators that allows to expand the production capacity of new and existing Cell factories as well as Advanced Cell Therapy applications while still operating within the ever restrictive confines of various regulatory bodies and industry guidelines.|
CO.DON is a german company active in the field of ATMP cartilage treatment with SperoxTM, approved by EMA in 2017.
The video shows the simulation of the innovative large-scale regenerative medicine laboratory where Spherox is going to be produced, located in Leipzig, Germany.
Also do not miss the speech “The use of enhanced GMP manufacturing techniques The success of Broad Scale production of EMA-approved Cartilage Substitute” by our Regenerative Medicine Specialist Marco Fadda & Giulietta Roël, Senior Scientist in the Research and Development Department of CO.DON AG at 3:30 pm on 20th of March.
See you at our tabletop, here:
See you in Pau!